Skip to content
OpenCapital
Get started

ADMA Biologics ADMA Acquired in-process research and development

Acquired in-process research and development at other companies

Erasca, Inc. logo
Erasca, Inc.ERAS
$150M—
ServiceTitan, Inc. logo
ServiceTitan, Inc.TTAN
$684.75K—
Mid-America Apartment Communities logo
Mid-America Apartment CommunitiesMAA
$75.26M+13.6%
Quantum Computing Inc. logo
Quantum Computing Inc.QUBT
$6.97M+133%
Cboe Global Markets logo
Cboe Global MarketsCBOE
$0-100%
Hamilton Lane logo
Hamilton LaneHLNE
$0-100%

Segments

By segment

See full
ADMA Bio Manufacturing$2.6M+214%
Plasma Collection Centers$0—

Other financials

Income statement

See full
Revenue$114.5M-0.3%
Gross profit$80.8M+32.2%
Operating income$58.3M+67.1%
Net income$45.3M+68.5%
EPS (diluted)$0.19+72.7%

Balance sheet

See full
Cash & equivalents$138.2M+92.9%
Total debt$204.4M+2,055%
Total equity$390.3M+4.5%
Total assets$665.2M+30.3%

Cash flow

See full
Operating cash flow$58.2M+396%
CapEx$2.5M-45.9%
Free cash flow$55.7M+329%

Valuation

See full
Market cap$2.01B-54.5%
Enterprise value$2.08B-52.5%
P/E12.2×-9.2×
P/S4×-5.7×

Profitability

See full
Gross margin61.3%+8.7pp
Operating margin42.1%+9.0pp
Net margin32.4%-12.6pp
FCF margin21.2%+1.4pp

Returns & leverage

See full
Return on equity43.3%-35.2pp
Debt / equity0.5×+0.5×
Current ratio7×+0.4×

Where this comes from

Reported directly by ADMA Biologics in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about ADMA Biologics's acquired in-process research and development.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ADMA Biologics's acquired in-process research and development?
ADMA Biologics (ADMA) reported acquired in-process research and development of $2.6M in Q1 2026.
How has ADMA Biologics's acquired in-process research and development changed year-over-year?
ADMA Biologics's acquired in-process research and development increased by 214.4% year-over-year, from $826K to $2.6M.
What is the long-term trend for ADMA Biologics's acquired in-process research and development?
Over 2 years (2023 to 2025), ADMA Biologics's acquired in-process research and development has grown at a 20.1% compound annual growth rate (CAGR), from $3.3M to $4.76M.
What does acquired in-process research and development mean?
Refers to the cash expenditures or fair value allocated to the acquisition of research and development projects that have not yet reached technological feasibility. This metric highlights a company's strategy for inorganic growth and long-term pipeline expansion through external innovation.